Sopharma AD: directors' dealings · Bulgaria · BSE-Sofia (FSC) BSE-BG:sopharma-ad BG BG · BSE-Sofia (FSC) Mcap 3.9Bn€ Healthcare
Explore the full directors' dealings record of Sopharma AD, a listed equity based in Bulgaria. Shares are listed on BG BG, under the authority of BSE-Sofia (FSC). Operating in the Healthcare sector, Sopharma AD has published 149 insider filings. Market capitalisation: €3.9bn. The latest transaction was disclosed on 21 May 2026 — MAR Art. 17 — Insider information. The full history is openly available.
Financial data FY ended December 2025 · cache
Income statement
Revenue 2.61 Bn€
Gross profit 604.1 M€ 23% margin
Net income 133.5 M€ 5.1% margin
Valuation
PER (trailing) 5.8x
P/Book 4.0x
Beta 0.07
Balance sheet & cash
Market cap 3.90 Bn€
Total debt 612.9 M€
Free Cash Flow −124.3 M€
Debt / Equity 62%
Profitability & ownership
ROE 15.5%
ROA 4.3%
% insiders 66.4%
% institutions 0.2%
Last declaration on 21 May 2026
Declarations 149 total
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:158257 · 21 May 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:158060 · 14 May 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:157887 · 7 May 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:157847 · 6 May 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:157518 · 28 Apr 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:157238 · 16 Apr 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:157101 · 2 Apr 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:157090 · 1 Apr 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:156709 · 19 Mar 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:156725 · 19 Mar 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:156532 · 5 Mar 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:156517 · 5 Mar 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:156535 · 5 Mar 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:156529 · 5 Mar 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:156536 · 5 Mar 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:156513 · 4 Mar 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:156205 · 19 Feb 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:156026 · 5 Feb 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:156013 · 4 Feb 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:155685 · 22 Jan 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:155677 · 21 Jan 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:155673 · 21 Jan 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:155676 · 21 Jan 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:155675 · 21 Jan 2026 details not loaded
Executives ● MAR Art. 17 — Insider information0 BSE-BG
BSE-BG:155510 · 8 Jan 2026 details not loaded
25 of 149 declarations
Load more (124 remaining) About Sopharma AD Sopharma AD is a Bulgarian company engaged in the production and distribution of pharmaceuticals. It is listed on the Bulgarian Stock Exchange under the symbol XBUL.